Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.
Patricia P WadowskiConstantin WeikertJoseph PultarSilvia LeeBeate EichelbergerRenate KoppensteinerIrene M LangSimon PanzerThomas GremmelPublished in: Cardiovascular drugs and therapy (2020)
Ticagrelor inhibits TLR-1/2 and PAR mediated platelet activation in ACS patients more strongly than prasugrel.